Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PM577a in Wilson Disease
NCT07748403Phase 2Recruiting
- Sponsor
- Prime Medicine, Inc.
- Start
- Sep 2026
- Primary completion
- Nov 2028
- Countries
- 2
01
Overview
A Phase 2 trial of PM577a in Wilson disease (WD), sponsored by Prime Medicine, Inc.. Started Sep 2026; status: recruiting.
02
Drugs
PM577a
03
Conditions
Wilson disease (WD)
Beyond the preview
Go deeper on NCT07748403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07748403.